A health care company has agreed to pay more than $18 million after a whistleblower raised alarms about mold near a production line for sterile IV bags.
U.S. Justice Department officials announced the developments with Baxter Healthcare Corp. late Thursday. The company will pay the $18 million to resolve civil and criminal matters after issues with mold in part of its Marion, North Carolina plant in 2011 and 2012.
Tony Scheer, one of two attorneys representing Wall, told Eyewitness News that Wall tried to get managers at Baxter to stop the production line. When they didn’t, he went to the Federal Drug Administration, Scheer said.
“It’s truly unfortunate that a group of managers at that plant ignored the best efforts of Mr. Wall and some others at the plant to get them to stop it,” Scheer said.